Marcelle Moulin-Sallanon

Marcelle Moulin-Sallanon

Auto-generated profile, based on publicly available information

Marcelle Moulin-Sallanon

Division of Adult Psychiatry, Department of Mental Health and Psychiatry, University Hospitals of Geneva, Switzerland; INSERM Unit 1039, J. Fourier University, La Tronche, France

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 1989 in Neuroscience
Verified
Journal Article
Closed access
MSM. Sallanon
M. Sallanon
MDM. Denoyer
M. Denoyer
KKK. Kitahama
K. Kitahama
CAC. Aubert
C. Aubert
NGN. Gay
N. Gay
MJM. Jouvet
M. Jouvet

22 February 2008 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
ACAnthony W. Coleman
Anthony W. Coleman
SJSaid Jebors
Said Jebors
SCSebastien Cecillon
Sebastien Cecillon
PPPascale Perret
Pascale Perret
DGDominique Garin
Dominique Garin
MMMarcelle Moulin
Marcelle Moulin
The acute in vivo toxicity of para-35S-sulfonato-calix[4]arene has been determined, with no toxicity for doses up to 100 mg kg−1. Biodistribution shows that the molecule is rapidly cleared in urine, that it does not accumulate in the liver and spleen, and is not observed in the brain.

1 September 2013 in International Journal of Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
BTBenjamin Tournier
Benjamin Tournier
TSThierry Steimer
Thierry Steimer
PMPhilippe Millet
Philippe Millet
MMMarcelle Moulin-Sallanon
Marcelle Moulin-Sallanon
PVPhilippe Vallet
Philippe Vallet
NGNathalie Ginovart
Nathalie Ginovart
High novelty-seeking has been related to an increased risk for developing addiction, but the neurobiological mechanism underlying this relationship is unclear. We investigated whether differences in dopamine (DA) D2/3-receptor (D2/3R) function underlie phenotypic divergence in novelty-seeking and vulnerability to addiction. Measures of D2/3R availability using the D2R-preferring antagonist [18F]Fallypride, and the D3R-preferring agonist [3H]-(+)-PHNO and of DA-related gene expression and behaviours were used to characterize DA signalling in Roman high- (RHA) and low-avoidance (RLA) rats, which respectively display high and low behavioural responsiveness both to novelty and psychostimulant exposure. When compared to RLA rats, high novelty-responding RHAs had lower levels of D2R, but not D3R, binding and mRNA in substantia nigra/ventral tegmental area (SN/VTA) and showed behavioural evidence of D2-autoreceptor subsensitivity. RHA rats also showed a higher expression of the tyrosine hydroxylase gene in SN/VTA, higher levels of extracellular DA in striatum and augmentation of the DA-releasing effects of amphetamine (Amph), suggesting hyperfunctioning of midbrain DA neurons. RHA rats also exhibited lower availabilities and functional sensitivity of D2R, but not D3R, in striatum, which were inversely correlated with individual scores of novelty-seeking, which, in turn, predicted the magnitude of Amph-induced behavioural sensitization. These results indicate that innately low levels of D2R in SN/VTA and striatum, whether they are a cause or consequence of the concomitantly observed elevated DA tone, result in a specific pattern of DA signalling that may subserve novelty-seeking and vulnerability to drug use. This suggests that D2R deficits in SN/VTA and striatum could both constitute neurochemical markers of an addiction-prone phenotype.

1 January 1991 in Brain Research
Verified
Journal Article
Closed access
MDMichel Denoyer
Michel Denoyer
MSMarcelle Sallanon
Marcelle Sallanon
CBColette Buda
Colette Buda
KKKunio Kitahama
Kunio Kitahama
MJMichel Jouvet
Michel Jouvet

1 January 1989 in Neuroscience
Verified
Journal Article
Closed access
MDM. Denoyer
M. Denoyer
MSM. Sallanon
M. Sallanon
KKK. Kitahama
K. Kitahama
CAC. Aubert
C. Aubert
MJM. Jouvet
M. Jouvet

1 April 1995 in Neuroscience Letters
Verified
Journal Article
Closed access
MTM. Tourev
M. Tourev
MSM. Sallanon-Moulin
M. Sallanon-Moulin
MJM. Jouvet
M. Jouvet